NC
Nataraju Chennapai
About Nataraju Chennapai
Data last updated:
Nataraju Chennapai has 8 years in corporate governance. Holds Director role. Currently with 1 company, including Rit Qik Homoeo Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Rit Qik Homoeo Pharmaceuticals Private Limited at ₹49 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Rit Qik Homoeo Pharmaceuticals Private Limited U74999TG2018PTC126291 | Director | 27 Aug 2018 | 2018 | ₹49 Lakh (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nataraju Chennapai
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nataraju Chennapai
Nataraju Chennapai has 8 years in corporate governance. Holds Director role. Currently with 1 company, including Rit Qik Homoeo Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Rit Qik Homoeo Pharmaceuticals Private Limited at ₹49 Lakh (FY 2025).
Nataraju Chennapai is associated with 1 company as Director, including Rit Qik Homoeo Pharmaceuticals Private Limited (₹49 Lakh).
Nataraju Chennapai has expertise in General Business.
Nataraju Chennapai has 8 years in corporate governance.
By reported revenue, the largest current company of Nataraju Chennapai is Rit Qik Homoeo Pharmaceuticals Private Limited, with revenue of ₹49 Lakh (FY 2025).
Nataraju Chennapai currently holds positions at 1 company: Rit Qik Homoeo Pharmaceuticals Private Limited (₹49 Lakh).